{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:08:56Z","timestamp":1783069736571,"version":"3.54.6"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jri.2020.103101","type":"journal-article","created":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T10:57:05Z","timestamp":1582369025000},"page":"103101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Preeclampsia before fetal viability in women with primary antiphospholipid syndrome- materno-fetal outcomes in a series of 7 cases"],"prefix":"10.1016","volume":"138","author":[{"given":"Karoline","family":"Mayer-Pickel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila","family":"Cervar-Zivkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Sch\u00f6ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Moertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"February(4)","key":"10.1016\/j.jri.2020.103101_bib0005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/14767058.2017.1289511","article-title":"Treatment of preeclampsia with hydroxychloroquine: a review","volume":"31","author":"Abd Rahman","year":"2018","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"key":"10.1016\/j.jri.2020.103101_bib0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0029-7844(01)01747-1","article-title":"ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia","volume":"99","author":"ACOG Committee on Practice Bulletins--Obstetrics","year":"2002","journal-title":"Obstet. Gynecol."},{"issue":"February","key":"10.1016\/j.jri.2020.103101_bib0015","first-page":"11","article-title":"Treatment of refractory poor aPL-related obstetric outcomes with TNF-alpha blockers: Maternal-fetal outcomes in a series of 18 cases","author":"Alijotas-Reig","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"issue":"October(4 Pt 2)","key":"10.1016\/j.jri.2020.103101_bib0020","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/0029-7844(96)00098-1","article-title":"Preeclampsia and liver infarction in early pregnancy associated with the antiphospholipid syndrome","volume":"88","author":"Alsulyman","year":"1996","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jri.2020.103101_bib0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/AOG.0b013e31820a61f9","article-title":"ACOG practice bulletin No. 118: antiphospholipid syndrome","volume":"117","author":"American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jri.2020.103101_bib0030","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2174\/138161212799504803","article-title":"Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials","volume":"18","author":"Antonopoulos","year":"2012","journal-title":"Curr Pharm."},{"issue":"December(3)","key":"10.1016\/j.jri.2020.103101_bib0035","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.semarthrit.2011.05.007","article-title":"HELLP syndrome and its relationship with antiphospholipid syndrome and antiphospholipid antibodies","volume":"41","author":"Appenzeller","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"issue":"January (1)","key":"10.1016\/j.jri.2020.103101_bib0040","first-page":"485","article-title":"TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss","volume":"174","author":"Berman","year":"2005","journal-title":"Immunology"},{"issue":"January (3)","key":"10.1016\/j.jri.2020.103101_bib0045","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1182\/blood-2013-08-522623","article-title":"Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study","volume":"123","author":"Bouvier","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jri.2020.103101_bib0050","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1182\/blood-2011-02-339234","article-title":"First trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss","volume":"117","author":"Bramham","year":"2011","journal-title":"Blood"},{"issue":"April(4)","key":"10.1016\/j.jri.2020.103101_bib0055","first-page":"541","article-title":"The association of antiphospholipid antibodies with severe preeclampsia","volume":"73","author":"Branch","year":"1989","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jri.2020.103101_bib0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0002-9378(00)70500-X","article-title":"A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group","volume":"182","author":"Branch","year":"2000","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.jri.2020.103101_bib0065","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","article-title":"Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb. Haemost."},{"issue":"16","key":"10.1016\/j.jri.2020.103101_bib0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12884-016-0902-3","article-title":"Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta","volume":"20","author":"Brownfoot","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"issue":"June","key":"10.1016\/j.jri.2020.103101_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.02.003","article-title":"The treatment of anti-phospholipid syndrome: a comprehensive clinical approach","volume":"90","author":"Chighizola","year":"2018","journal-title":"J. Autoimmun."},{"issue":"June(3)","key":"10.1016\/j.jri.2020.103101_bib0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11926-007-0035-9","article-title":"Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?","volume":"9","author":"Clark","year":"2007","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jri.2020.103101_bib0085","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2020.103101_bib0090","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1479-828X.1980.tb00773.x","article-title":"Treatment of severe pre-eclampsia by plasma exchange","volume":"20","author":"d\u2019Apice","year":"1980","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"issue":"March(1)","key":"10.1016\/j.jri.2020.103101_bib0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0301-2115(98)00252-8","article-title":"Tumor necrosis factor during pregnancy and at the onset of labor and spontaneous abortion","volume":"83","author":"Daher","year":"1999","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.jri.2020.103101_bib0100","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1161\/01.CIR.96.12.4380","article-title":"Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice","volume":"96","author":"Edwards","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jri.2020.103101_bib0105","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijgo.2007.05.045","article-title":"Plasmapheresis and pregnancy outcome in patients with antiphospholipid syndrome","volume":"99","author":"El-Haieg","year":"2007","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.jri.2020.103101_bib0110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJM196408202710803","article-title":"Late vascular effects of toxemia of pregnancy","volume":"271","author":"Epstein","year":"1964","journal-title":"N. Engl. J. Med."},{"issue":"June (Suppl 3)","key":"10.1016\/j.jri.2020.103101_bib0115","first-page":"iii23","article-title":"Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers","volume":"47","author":"Erkan","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"January(1)","key":"10.1016\/j.jri.2020.103101_bib0120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/OGX.0000000000000522","article-title":"Pravastatin for preventing and treating preeclampsia: a systematic review","volume":"73","author":"Esteve-Valverde","year":"2018","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.jri.2020.103101_bib0125","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(87)92584-0","article-title":"Successful removal of anti-phospholipid antibody during pregnancy using plasma exchange and low-dose prednisolone","volume":"31","author":"Frampton","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jri.2020.103101_bib0130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/HYPERTENSIONAHA.114.03587","article-title":"Chronic Hydroxychloroquine improves endothelial dysfunction and protects kidney in a moue model of systemic lupus erythematodes","volume":"64","author":"Gomez-Guzan","year":"2014","journal-title":"Hypertension"},{"issue":"October","key":"10.1016\/j.jri.2020.103101_bib0135","first-page":"21","article-title":"Upgrading therapy strategy improves pregnancy outcome in antiphospholipid syndrome: a cohort management study","author":"Hoxha","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"September(7)","key":"10.1016\/j.jri.2020.103101_bib0140","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0143-4004(77)90005-4","article-title":"Tumour necrosis factor-alpha induces cyclo-oxygenase-2 gene expression in first trimester trophoblasts: suppression by glucocorticoids and NSAIDs","volume":"18","author":"Imseis","year":"1997","journal-title":"Placenta"},{"issue":"September(10)","key":"10.1016\/j.jri.2020.103101_bib0145","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1471-0528.2008.01827.x","article-title":"Cerebral palsy and restricted growth status at birth: population-based case-control study","volume":"115","author":"Jacobsson","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.jri.2020.103101_bib0150","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bcp.12872","article-title":"Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis","volume":"81","author":"Kaplan","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jri.2020.103101_bib0155","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bcp.12872","article-title":"Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis","volume":"81","author":"Kaplan","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6869","key":"10.1016\/j.jri.2020.103101_bib0160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bmj.306.6869.24","article-title":"Initiation of hypertension in utero and its amplification throughout life","volume":"306","author":"Law","year":"1993","journal-title":"BMJ"},{"issue":"February(2)","key":"10.1016\/j.jri.2020.103101_bib0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/ard.2003.019000","article-title":"Piette JC the HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women","volume":"64","author":"Le Thi Thuong","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"72","key":"10.1016\/j.jri.2020.103101_bib0170","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2165\/11632010-000000000-00000","article-title":"Statins and pregnancy: between supposed risks and theoretical benefits","volume":"16","author":"Lecarpentier","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.jri.2020.103101_bib0175","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1161\/HYPERTENSIONAHA.114.03115","article-title":"Clinical improvement and successful pregnancy in a preeclamptic patient with antiphospholipid syndrome treated with pravastatin","volume":"63","author":"Lefkou","year":"2014","journal-title":"Hypertension"},{"issue":"7028","key":"10.1016\/j.jri.2020.103101_bib0180","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/bmj.312.7028.406","article-title":"Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50\u201360 years","volume":"312","author":"Lithell","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.jri.2020.103101_bib0185","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.intimp.2015.06.006","article-title":"Immunotherapy in antiphospholipid syndrome","volume":"27","author":"Lopez-Pedrera","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jri.2020.103101_bib0190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jca.2920090302","article-title":"Plasma exchange for preeclampsia: II. Unsuccessful antepartum utilization for severe preeclampsia with or without HELLP syndrome","volume":"9","author":"Martin","year":"1994","journal-title":"J. Clin. Apher."},{"issue":"October (5)","key":"10.1016\/j.jri.2020.103101_bib0195","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1160\/TH16-02-0169","article-title":"LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia. A systematic review and meta-analysis","volume":"116","author":"Mastrolia","year":"2016","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.jri.2020.103101_bib0200","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.autrev.2015.01.012","article-title":"The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study","volume":"14","author":"Mekinian","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jri.2020.103101_bib0205","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.autrev.2015.01.012","article-title":"The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study","volume":"14","author":"Mekinian","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jri.2020.103101_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2016.07.003","article-title":"Prevention & treatment of obstetrical complications in APS: is hydroxychloroquine the Holy Grail we are looking for?","author":"Meroni","year":"2016","journal-title":"J. Autoimmun. Cell Responses"},{"issue":"December","key":"10.1016\/j.jri.2020.103101_bib0215","first-page":"1","article-title":"Prevention & treatment of obstetrical complications in APS: is hydroxychloroquine the Holy Grail we are looking for?","volume":"75","author":"Meroni","year":"2016","journal-title":"J. Autoimmun. Cell Responses"},{"key":"10.1016\/j.jri.2020.103101_bib0220","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipide syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jri.2020.103101_bib0225","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/GCO.0000000000000026","article-title":"Statins in pregnancy","volume":"25","author":"Morton","year":"2013","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"March(3)","key":"10.1016\/j.jri.2020.103101_bib0230","first-page":"452","article-title":"Seidman DS the cognitive outcome of full-term small for gestational age infants at late adolescence","volume":"85","author":"Paz","year":"1995","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jri.2020.103101_bib0235","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection. Subcommittee on lupus anticoagulant\/antiphospholipid antibody of the scientific and standardisation committee of the international society on thrombosis and haemostasis","volume":"7","author":"Pengo","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jri.2020.103101_bib0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11926-010-0141-y","article-title":"Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematodes and in antiphospholipid antibody-postive patients","volume":"13","author":"Petri","year":"2011","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jri.2020.103101_bib0245","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood-2008-03-144204","article-title":"Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers","volume":"112","author":"Rand","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jri.2020.103101_bib0250","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2009-04-213520","article-title":"Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug","volume":"115","author":"Rand","year":"2010","journal-title":"Blood"},{"issue":"7105","key":"10.1016\/j.jri.2020.103101_bib0255","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/bmj.315.7105.396","article-title":"Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976","volume":"315","author":"Rich-Edwards","year":"1997","journal-title":"Br. Med. J."},{"issue":"November (9955)","key":"10.1016\/j.jri.2020.103101_bib0260","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(14)60793-5","article-title":"Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial","volume":"384","author":"Rodger","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jri.2020.103101_bib0265","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.autrev.2006.11.002","article-title":"Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature","volume":"6","author":"Ruffatti","year":"2007","journal-title":"Autoimmun. Rev."},{"issue":"115","key":"10.1016\/j.jri.2020.103101_bib0270","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jri.2016.03.004","article-title":"Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study","volume":"29","author":"Ruffatti","year":"2016","journal-title":"J. Reprod. Immunol."},{"issue":"April(4)","key":"10.1016\/j.jri.2020.103101_bib0275","first-page":"639","article-title":"Effect of additional treatments combined with conventional therapies in pregnant patients with high-risk antiphospholipid syndrome: a multicentre study","volume":"118","author":"Ruffatti","year":"2018","journal-title":"Thromb. Haemost."},{"issue":"376","key":"10.1016\/j.jri.2020.103101_bib0280","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"30","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jri.2020.103101_bib0285","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1186\/ar3895","article-title":"Hydroxychloroquine is associated with impaired interferon-alpha and tumor-necrosis factor alpha production by plasmacytoid dendritic cells in systemic lupus erythematodes","volume":"14","author":"Sacre","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"9608","key":"10.1016\/j.jri.2020.103101_bib0290","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0140-6736(08)60136-1","article-title":"An overview of mortality and sequelae of preterm birth from infancy to adulthood","volume":"371","author":"Saigal","year":"2008","journal-title":"Lancet."},{"issue":"7","key":"10.1016\/j.jri.2020.103101_bib0295","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0036-1592336","article-title":"Pregnancy and Antiphospholipid Syndrome","volume":"42","author":"Schreiber","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.jri.2020.103101_bib0300","first-page":"136","article-title":"Possible role for exchange plasmapheresis with fresh frozen plasma for maternal indications in selected cases of preeclampsia and eclampsia","volume":"68","author":"Schwartz","year":"1986","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jri.2020.103101_bib0305","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajog.2015.09.078","article-title":"The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies","volume":"214","author":"Sciascia","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2020.103101_bib0310","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajog.2015.09.078","article-title":"The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies","volume":"214","author":"Sciascia","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2020.103101_bib0315","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0897.1998.tb00394.x","article-title":"The selective use of heparin\/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization","volume":"40","author":"Sher","year":"1998","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2020.103101_bib0320","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.autrev.2015.11.009","article-title":"Intravenous immunoglobulins and antiphospholipid syndrome: how, when and why? A review of the literature","volume":"15","author":"Tenti","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"July(7)","key":"10.1016\/j.jri.2020.103101_bib0325","first-page":"553","article-title":"Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease","volume":"9","author":"Tincani","year":"2007","journal-title":"Isr. Med. Assoc. J."},{"issue":"March(3)","key":"10.1016\/j.jri.2020.103101_bib0330","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/art.10957","article-title":"Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies","volume":"48","author":"Triolo","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"February","key":"10.1016\/j.jri.2020.103101_bib0335","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejogrb.2015.12.011","article-title":"FRUIT Investigators. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT","volume":"197","author":"van Hoorn","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"277","key":"10.1016\/j.jri.2020.103101_bib0340","article-title":"Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus","volume":"17","author":"Virdis","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jri.2020.103101_bib0345","first-page":"205","article-title":"Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restore annexin A5 expression","author":"Wu","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"January(1)","key":"10.1016\/j.jri.2020.103101_bib0350","first-page":"44","article-title":"Tumor necrosis factor receptor 1 expression and early spontaneous abortion","volume":"88","author":"Yu XW","year":"2005","journal-title":"Int. J. Gynaecol. Obstet."}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503782030022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503782030022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:25:23Z","timestamp":1759033523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503782030022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":70,"alternative-id":["S016503782030022X"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2020.103101","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preeclampsia before fetal viability in women with primary antiphospholipid syndrome- materno-fetal outcomes in a series of 7 cases","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2020.103101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103101"}}